Northern Light Venture Capital has led a US$25 million series B round of financing in TenNor Therapeutics, a clinical stage company focused on developing dual-acting antibiotics. Existing investors Frontline BioVentures, WuXi PharmaTech Healthcare Fund I, Oriza Venture Capital and Relativity Healthcare Fund also participated in the round. The company says it will use the proceeds […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.